Nearly 800,000 people in the United States suffer a stroke each year – one every 40 seconds. It is the fourth leading cause of death and a leading cause of disability. From cooling the brain to infusing stem cells, UTHealth is working hard to change that. An international leader in research and clinical care, UTHealth was one of the original sites in the ground-breaking trial that found tissue plasminogen activator (tPA) could help stroke patients. Researchers are now studying autologous stem cells, drugs that can be used in combination with tPA, other potential clot-busters and brain cooling for stroke. The UTHealth Department of Neurology Stroke Team has also established a strong telemedicine program that takes the best of clinical care and research to outlying hospitals and their patients. UTHealth neurologists continue to work with partners including the Mischer Neuroscience Institute at Memorial Hermann-Texas Medical Center and Harris Health System’s Lyndon B. Johnson Hospital to bring cutting-edge care to patients.
Members of the stroke program in the Department of Neurology at The University of Texas Health Science Center (UTHealth) Medical School, made a total of 22 presentations at the recent American Stroke Association’s International Stroke Conference 2015.Continue reading »
The Stroke Team at The University of Texas Health Science Center at Houston (UTHealth) Medical School will host the Stomp Out Stroke Festival on May 2 at Discovery Green, 1500 McKinney St., in downtown Houston.Continue reading »
For the first time in the world, researchers at The University of Texas Health Science Center at Houston (UTHealth) were able to enroll patients at other hospitals into an acute stroke clinical trial.Continue reading »